140 related articles for article (PubMed ID: 18958755)
21. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
22. [Therapeutic efficacy of hematopoietic stem cell transplantation in patients with chronic myelogenous leukemia].
Liu QF; Fan ZP; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1227-9, 1241. PubMed ID: 15567763
[TBL] [Abstract][Full Text] [Related]
23. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
Espigado I; Ríos E; Marín-Niebla A; Carmona M; Parody R; Pérez-Hurtado JM; Márquez FJ; Urbano-Ispizua A
Transplant Proc; 2008 Nov; 40(9):3104-5. PubMed ID: 19010208
[TBL] [Abstract][Full Text] [Related]
24. Stem cell transplantation for severe autoimmune diseases: progress and problems.
Marmont AM
Haematologica; 1998 Aug; 83(8):733-43. PubMed ID: 9793258
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
26. Autologous hematopoietic stem cell transplantation for autoimmune diseases.
Gratwohl A; Passweg J; Bocelli-Tyndall C; Fassas A; van Laar JM; Farge D; Andolina M; Arnold R; Carreras E; Finke J; Kötter I; Kozak T; Lisukov I; Löwenberg B; Marmont A; Moore J; Saccardi R; Snowden JA; van den Hoogen F; Wulffraat NM; Zhao XW; Tyndall A;
Bone Marrow Transplant; 2005 May; 35(9):869-79. PubMed ID: 15765114
[TBL] [Abstract][Full Text] [Related]
27. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
28. Immunoablation followed by autologous hematopoietic stem cell infusion for the treatment of severe autoimmune disease.
Rabusin M; Andolina M; Maximova N; Lepore L; Parco S; Tuveri G; Jankovic G
Haematologica; 2000 Nov; 85(11 Suppl):81-5. PubMed ID: 11268330
[TBL] [Abstract][Full Text] [Related]
29. Reticulated platelet counts correlate with treatment response in patients with idiopathic thrombocytopenic purpura and help identify the complex causes of thrombocytopenia in patients after allogeneic hematopoietic stem cell transplantation.
Thomas-Kaskel AK; Mattern D; Köhler G; Finke J; Behringer D
Cytometry B Clin Cytom; 2007 Jul; 72(4):241-8. PubMed ID: 17266149
[TBL] [Abstract][Full Text] [Related]
30. Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograft.
di Grazia C; Raiola AM; Van Lint MT; Lamparelli T; Gualandi F; Berisso G; Bregante S; Dominietto A; Mordini N; Bruno B; Frassoni F; Bacigalupo A
Haematologica; 2001 Jun; 86(6):646-51. PubMed ID: 11418375
[TBL] [Abstract][Full Text] [Related]
31. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial.
Brinkman DM; de Kleer IM; ten Cate R; van Rossum MA; Bekkering WP; Fasth A; van Tol MJ; Kuis W; Wulffraat NM; Vossen JM
Arthritis Rheum; 2007 Jul; 56(7):2410-21. PubMed ID: 17599770
[TBL] [Abstract][Full Text] [Related]
32. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003.
Gratwohl A; Baldomero H; Schmid O; Horisberger B; Bargetzi M; Urbano-Ispizua A
Bone Marrow Transplant; 2005 Oct; 36(7):575-90. PubMed ID: 16086045
[TBL] [Abstract][Full Text] [Related]
33. Allogeneic HSCT for autoimmune diseases: conventional conditioning regimens.
Nash RA
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S77-80. PubMed ID: 12931249
[TBL] [Abstract][Full Text] [Related]
34. Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant.
Blau IW; Basara N; Bischoff M; Günzelmann S; Römer E; Kirsten D; Schmetzer B; Kiehl MG; Fauser AA
Bone Marrow Transplant; 2000 Jan; 25(1):41-5. PubMed ID: 10654013
[TBL] [Abstract][Full Text] [Related]
35. Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry.
Gross TG; Filipovich AH; Conley ME; Pracher E; Schmiegelow K; Verdirame JD; Vowels M; Williams LL; Seemayer TA
Bone Marrow Transplant; 1996 May; 17(5):741-4. PubMed ID: 8733691
[TBL] [Abstract][Full Text] [Related]
36. Haematopoietic stem cell transplantation for autoimmune disorders.
Saccardi R; Di Gioia M; Bosi A
Curr Opin Hematol; 2008 Nov; 15(6):594-600. PubMed ID: 18832930
[TBL] [Abstract][Full Text] [Related]
37. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.
Diehl LF; Ketchum LH
Semin Oncol; 1998 Feb; 25(1):80-97. PubMed ID: 9482530
[TBL] [Abstract][Full Text] [Related]
38. Stem cell transplantation for patients with Evans syndrome.
Benesch M; Urban C; Platzbecker U; Passweg J
Expert Rev Clin Immunol; 2009 May; 5(3):341-8. PubMed ID: 20477011
[TBL] [Abstract][Full Text] [Related]
39. Ocular findings after allogeneic hematopoietic stem cell transplantation.
Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
[TBL] [Abstract][Full Text] [Related]
40. Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease.
Musso M; Porretto F; Crescimanno A; Bondi F; Polizzi V; Scalone R
Am J Hematol; 2001 Feb; 66(2):75-9. PubMed ID: 11421302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]